|1.||Sola-Penna, Mauro: 5 articles (06/2013 - 01/2009)|
|2.||Zancan, Patricia: 3 articles (06/2013 - 01/2009)|
|3.||Yang, Qiong: 2 articles (08/2015 - 03/2014)|
|4.||Gao, Chunsheng: 2 articles (08/2015 - 03/2014)|
|5.||Li, Shuo: 2 articles (08/2015 - 03/2014)|
|6.||Rodríguez-Enríquez, Sara: 2 articles (05/2014 - 05/2006)|
|7.||Moreno-Sánchez, Rafael: 2 articles (05/2014 - 05/2006)|
|8.||Marín-Hernández, Alvaro: 2 articles (05/2014 - 05/2006)|
|9.||Da Silva, Daniel: 2 articles (06/2013 - 08/2010)|
|10.||Du, Zhengde: 1 article (08/2015)|
03/01/1991 - "6. The present results demonstrate that the decrease in hepatic phosphofructokinase-1 activity occurring in sepsis does not appear to reflect alterations in the concentration of fructose 2,6-bisphosphate."
03/01/1991 - "Hepatic phosphofructokinase-1 activity and fructose 2,6-bisphosphate levels in patients with abdominal sepsis."
03/01/1991 - "In the present study hepatic phosphofructokinase-1 activity as well as phosphofructokinase-2 activity and the concentration of fructose 2,6-bisphosphate were assayed to determine if they might contribute to the derangement of carbohydrate metabolism seen commonly in sepsis. "
10/28/1994 - "The decline in the rate of gluconeogenesis also correlated with an inhibition of flux through phosphoenolpyruvate carboxykinase but not with alterations in flux through either pyruvate kinase or 6-phosphofructo-1-kinase, suggesting that a nitric oxide-induced inhibition of phosphoenolpyruvate carboxykinase may underlie the decreased glucose production in sepsis."
12/01/2012 - "This present study explored the association of Pyruvate Kinase isozyme M2 (PKM2), Phosphofructokinase 1 (PFK-1) and Adenine nucleotide translocator 1 (ANT1) with cervical carcinoma. "
06/01/1981 - "Cytotoxic effect of dactylarin on Ehrlich ascites carcinoma cells is caused by the inhibition of some SH-dependent glycolytic enzymes, especially of hexokinase (EC 184.108.40.206), glyceraldehyde-3-phosphate dehydrogenase (EC 220.127.116.11) and 6-phosphofructokinase (EC 18.104.22.168). "
|3.||Alzheimer Disease (Alzheimer's Disease)
05/01/1991 - "The activities of hexokinase and 6-phosphofructokinase were decreased whereas that of phosphorylase increased in response to starvation. "
01/01/1991 - "4. The ratio of fructose-6-phosphate/fructose-1,6-bisphosphate concentration in mammary tissue increased 9-fold during the first 6 hr starvation, indicating an inhibition of 6-phosphofructo-1-kinase. "
01/01/1986 - "This short period of starvation did not mimic the effect of diabetes on 6-phosphofructokinase activity. "
12/15/1982 - "2. The activities of the ketone-body-utilizing enzymes were lower than those of hexokinase or 6-phosphofructokinase, unlike in muscle and brain, and were not affected by starvation. "
11/01/1985 - "Starvation of the donor animal decreased the activities of hexokinase and 6-phosphofructokinase, whereas it increased those of glucose-6-phosphatase and fructose-bisphosphatase. "
07/02/2015 - "Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations."
08/01/2011 - "This result directly correlates with the inhibition promoted by CTZ on the activity of the major regulatory glycolytic enzyme 6-phosphofructo-1-kinase (PFK) that was observed in tumor tissues (84% inhibition) but not in control tissues. "
01/01/2011 - "Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism."
01/01/2009 - "Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity."
05/01/2014 - "Regardless of the experimental/environmental conditions and the rate of lactate production, the flux-control of cancer glycolysis is robust in the sense that it involves the same steps: glucose transport, hexokinase, hexosephosphate isomerase and glycogen degradation, all at the beginning of the pathway; these steps together with phosphofructokinase 1 also control glycolysis in normal cells. "
|4.||Adenine Nucleotide Translocator 1
|5.||Phosphofructokinase-2 (Phosphofructokinase 2)